Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Watson

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 20, 2019
The Novel CYP2A6 Inhibitor, DLCI-1, Decreases Nicotine Self-Administration in MiceYen-Chu Chen, James P Fowler, Jing Wang, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 24, 2007
Identification of a candidate gene for the wheat endopeptidase Ep-D1 locus and two other STS markers linked to the eyespot resistance gene Pch1Jeffrey M Leonard, Christy J W Watson, Arron H Carter, et al.
The Journal of Clinical Investigation|January 15, 1996
In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthmaC R Turner, R Breslow, M J Conklyn, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomyJ B Cheng, J W Watson, C J Pazoles, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonistsR J Chambers, G W Antognoli, J B Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Discovery of CP-199,330 and CP-199,331: two potent and orally efficacious cysteinyl LT1 receptor antagonists devoid of liver toxicityR J Chambers, A Marfat, G W Antognoli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 2, 2018
Nicotine-<i>N</i>'-Oxidation by Flavin Monooxygenase EnzymesYadira X Perez-Paramo, Gang Chen, Joseph H Ashmore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 17, 2022
Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in SmokersYadira X Perez-Paramo, Christy J W Watson, Gang Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
N-carbamoyl analogs of Zafirlukast: potent receptor antagonists of leukotriene D4M F Brown, A Marfat, G Antognoli, et al.
Journal of Medicinal Chemistry|January 5, 1996
Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferretA J Duplantier, M S Biggers, R J Chambers, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Pharmacology and Experimental Therapeutics|October 20, 2019
The Novel CYP2A6 Inhibitor, DLCI-1, Decreases Nicotine Self-Administration in MiceYen-Chu Chen, James P Fowler, Jing Wang, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 24, 2007
Identification of a candidate gene for the wheat endopeptidase Ep-D1 locus and two other STS markers linked to the eyespot resistance gene Pch1Jeffrey M Leonard, Christy J W Watson, Arron H Carter, et al.
The Journal of Clinical Investigation|January 15, 1996
In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthmaC R Turner, R Breslow, M J Conklyn, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomyJ B Cheng, J W Watson, C J Pazoles, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonistsR J Chambers, G W Antognoli, J B Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Discovery of CP-199,330 and CP-199,331: two potent and orally efficacious cysteinyl LT1 receptor antagonists devoid of liver toxicityR J Chambers, A Marfat, G W Antognoli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 2, 2018
Nicotine-<i>N</i>'-Oxidation by Flavin Monooxygenase EnzymesYadira X Perez-Paramo, Gang Chen, Joseph H Ashmore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 17, 2022
Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in SmokersYadira X Perez-Paramo, Christy J W Watson, Gang Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
N-carbamoyl analogs of Zafirlukast: potent receptor antagonists of leukotriene D4M F Brown, A Marfat, G Antognoli, et al.
Journal of Medicinal Chemistry|January 5, 1996
Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferretA J Duplantier, M S Biggers, R J Chambers, et al.
Pageof 14